Related Experiment Video
Updated: Jan 29, 2026

16:55
Isolation & Characterization of Hoechstlow CD45negative Mouse Lung Mesenchymal Stem Cells
Published on: October 26, 2011
20.8K
Cell Surface Markers of Mesenchymal Stem Cells: Current Knowledge and Advances in Characterization Technologies
Angelo Santoro1, Manuela Grimaldi1, Carmen Marino1
1Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Salerno, Italy.
Life (Basel, Switzerland)
|January 28, 2026
Summary
Mesenchymal stem cells (MSCs) are key to regenerative medicine. This review details their surface markers, crucial for identifying MSCs and improving therapies for tissue repair and various disorders.
Area of Science:
- Stem Cell Biology
- Regenerative Medicine
- Immunology
Background:
- Mesenchymal stem cells (MSCs) possess multipotent differentiation capabilities and immunomodulatory functions, making them vital for tissue repair and regenerative therapies.
- Applications span cardiac, orthopedic, and hematological disorders, necessitating precise identification and characterization for efficacy and safety.
- Current MSC identification relies on plastic adherence, specific surface marker expression (CD105, CD73, CD90), lack of hematopoietic markers (CD45, CD34), and in vitro differentiation potential.
Purpose of the Study:
- To provide a comprehensive overview of the principal surface markers of mesenchymal stem cells (MSCs).
- To highlight the significance of these markers in stem cell biology.
- To discuss their role in clinical translation and therapeutic applications.
Main Methods:
- Literature review of studies focusing on mesenchymal stem cell surface markers.
- Analysis of established criteria for MSC identification and characterization.
- Synthesis of information on the functional relevance of key surface markers.
Main Results:
- MSCs are characterized by specific surface marker profiles, including CD105, CD73, and CD90, with minimal expression of hematopoietic markers.
- Understanding these marker expression patterns is critical for optimizing MSC isolation and therapeutic strategies.
- Surface markers play a significant role in modulating MSC behavior and therapeutic outcomes.
Conclusions:
- Accurate identification of MSCs via surface marker analysis is essential for advancing regenerative medicine.
- Further research into the functional significance of MSC surface markers will enhance therapeutic efficacy and minimize adverse effects.
- Targeting specific surface markers holds potential for improving MSC-based clinical applications.
Keywords:
MSC heterogeneitymesenchymal stem cellsphenotypic characterizationstromal subpopulationssurface marker profilingMore Related Videos
Related Concept Videos
Mesenchymal Stem Cells
5.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.6K
Cell-surface Signaling
54.3K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
54.3K
Adult Stem Cells
33.8K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.8K
Embryonic Stem Cells
32.4K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.4K
Embryonic Stem Cells
5.0K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.0K
Induced Pluripotent Stem Cells
28.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K

